Madopar Tablets 250 mg Tablets
PDF Leaflet Revision Date: 02 May 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Parkinsonism.
Dosage (summary)
Initial: u00bd tablet three times daily; Maintenance: 1 tablet three times daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not established in lactation.
Key Drug Interactions
- MAO inhibitors
- Sympathomimetics
- Neuroleptics
Contraindications
- Hypersensitivity to components
- Decompensated renal function
- Decompensated hepatic function
- Patients under 25 years
Common side effects
- Nausea
- Dyskinesia
- Somnolence
- Depression
Counselling Points
- Take 30 mins before or 1 hour after meals.
- Monitor for psychiatric side effects.
- Avoid driving if experiencing somnolence.
Serious warnings
- Neuroleptic malignant syndrome risk with abrupt withdrawal
- Somnolence and sudden sleep onset
- Impulse control disorders
Important Disclaimer
The Madopar Tablets 250 mg Tablets professional information leaflet below is the property of Roche Products and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
